Estimating required information size by quantifying diversity in random-effects model meta-analyses

被引:617
作者
Wetterslev, Jorn [1 ]
Thorlund, Kristian [1 ]
Brok, Jesper [1 ]
Gluud, Christian [1 ]
机构
[1] Univ Copenhagen Hosp, Rigshosp, Dept 3344, Ctr Clin Intervent Res,Copenhagen Trial Unit, DK-2100 Copenhagen O, Denmark
关键词
PERIOPERATIVE BETA-BLOCKERS; TRIAL SEQUENTIAL-ANALYSIS; NONCARDIAC SURGERY; EMPIRICAL-EVIDENCE; HETEROGENEITY; BIAS; LIMITATIONS; OUTCOMES; DESIGN;
D O I
10.1186/1471-2288-9-86
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: There is increasing awareness that meta-analyses require a sufficiently large information size to detect or reject an anticipated intervention effect. The required information size in a meta-analysis may be calculated from an anticipated a priori intervention effect or from an intervention effect suggested by trials with low-risk of bias. Methods: Information size calculations need to consider the total model variance in a meta-analysis to control type I and type II errors. Here, we derive an adjusting factor for the required information size under any random-effects model meta-analysis. Results: We devise a measure of diversity (D-2) in a meta-analysis, which is the relative variance reduction when the meta-analysis model is changed from a random-effects into a fixed-effect model. D-2 is the percentage that the between-trial variability constitutes of the sum of the between-trial variability and a sampling error estimate considering the required information size. D-2 is different from the intuitively obvious adjusting factor based on the common quantification of heterogeneity, the inconsistency (I-2), which may underestimate the required information size. Thus, D-2 and I-2 are compared and interpreted using several simulations and clinical examples. In addition we show mathematically that diversity is equal to or greater than inconsistency, that is D-2 >= I-2, for all meta-analyses. Conclusion: We conclude that D-2 seems a better alternative than I2 to consider model variation in any random-effects meta-analysis despite the choice of the between trial variance estimator that constitutes the model. Furthermore, D-2 can readily adjust the required information size in any random-effects model meta-analysis.
引用
收藏
页数:12
相关论文
共 37 条
[1]   Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis [J].
Afshari, Arash ;
Wetterslev, Jorn ;
Brok, Jesper ;
Moller, Ann .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7632) :1248-1251
[2]  
Al-Inany H.G., 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001750.PUB2
[3]   Meta-analysis, Simpson's paradox, and the number needed to treat [J].
Altman D.G. ;
Deeks J.J. .
BMC Medical Research Methodology, 2 (1) :1-5
[4]  
[Anonymous], GROUP SEQUENTIAL MET
[5]  
[Anonymous], 1997, COCHRANE DB SYST REV
[6]  
[Anonymous], COCHRANE DATABASE SY
[7]   Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis [J].
Bangalore, Sripal ;
Wetterslev, Jorn ;
Pranesh, Shruthi ;
Sawhney, Sabrina ;
Gluud, Christian ;
Messerli, Franz H. .
LANCET, 2008, 372 (9654) :1962-1976
[8]  
BROK J, 2008, INT J EPIDEMIOL, DOI DOI 10.1093/IEJ/DYN188
[9]   Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses [J].
Brok, Jesper ;
Thorlund, Kristian ;
Gluud, Christian ;
Wetterslev, Jorn .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (08) :763-769
[10]  
Bury RG, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858